Insider Shareholders with Direct Ownership of Verona Pharma PLC (VRNA)
This section provides a comprehensive overview of the insiders with direct ownership of Verona Pharma PLC (VRNA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Verona Pharma plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Zaccardelli
President and CEO |
7,063,552 | 11,282,904 | 15,345,784 $521 Million | 45 |
Nov 01, 2024
Reduced 1.58%
|
|
Mark W Hahn
Chief Financial Officer |
6,439,600 | 10,991,600 | 14,423,408 $489 Million | 42 |
Nov 01, 2024
Reduced 1.68%
|
|
Kathleen A. Rickard
Chief Medical Officer |
1,655,000 | 1,825,672 | 2,911,480 $98.8 Million | 34 |
Nov 01, 2024
Reduced 2.21%
|
|
Claire Poll
General Counsel |
1,178,800 | 2,522,376 | 2,017,391 $68.5 Million | 22 |
Oct 20, 2023
Added 9.02%
|
|
David R Ebsworth
Director |
196,000 | 23,096 | 880,643 $29.9 Million | 4 |
Aug 12, 2024
Added 3.93%
|
|
Anders Ullman
Director |
0 | 22,856 | 334,856 $11.4 Million | 2 |
May 04, 2021
Reduced 3.48%
|
|
Andrew Fisher
General Counsel |
300,000 | 0 | 300,000 $10.2 Million | 1 |
Oct 30, 2024
Added 50.0%
|
|
Martin Edwards
Director |
33,736 | 25,712 | 144,800 $4.91 Million | 3 |
Nov 20, 2023
Added 18.9%
|
|
Vikas Sinha
Director |
0 | 20,240 | 74,440 $2.53 Million | 2 |
May 04, 2021
Reduced 11.86%
|
|
Mahendra Shah
Director |
0 | 21,480 | 73,080 $2.48 Million | 2 |
May 04, 2021
Reduced 12.75%
|
|
Lisa Deschamps
Director |
116,000 | 45,680 | 70,320 $2.39 Million | 5 |
Feb 01, 2022
Reduced 14.23%
|
|
Kenneth Cunningham
Director |
0 | 26,216 | 66,584 $2.26 Million | 2 |
May 04, 2021
Reduced 16.45%
|